IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -58.62% | -84.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -58.62% | -84.94% | |||
| Cost of Revenue | 4,135.71% | -87.98% | |||
| Gross Profit | -3,973.33% | -80.26% | |||
| SG&A Expenses | -32.19% | -26.59% | |||
| Depreciation & Amortization | 478.23% | -133.82% | |||
| Other Operating Expenses | 87.20% | -35.43% | |||
| Total Operating Expenses | 44.53% | -35.38% | |||
| Operating Income | -46.00% | 32.18% | |||
| Income Before Tax | -382.50% | 120.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -373.53% | 120.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -373.53% | 120.39% | |||
| EBIT | -46.00% | 32.18% | |||
| EBITDA | -45.97% | 21.60% | |||
| EPS Basic | -262.79% | 118.78% | |||
| Normalized Basic EPS | -350.00% | 93.01% | |||
| EPS Diluted | -262.79% | 118.78% | |||
| Normalized Diluted EPS | -350.00% | 93.01% | |||
| Average Basic Shares Outstanding | 68.55% | 7.42% | |||
| Average Diluted Shares Outstanding | 68.24% | 7.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||